SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
BioMidwest
Humanetics Corporation to Present at the 2024 BIO International Convention in San Diego
May 31, 2024
 · 
2 min read
BioMidwest
Humanetics Corporation to Present at Investor and Partnering Conferences
February 7, 2024
 · 
4 min read
BioMidwest
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 6, 2024
 · 
1 min read
BioMidwest
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024
 · 
3 min read
Business
Major General (Ret.) Barbara R. Holcomb Joins Board at Humanetics
December 12, 2023
 · 
3 min read
Business
Humanetics Corporation Appoints Dr. Colin Chinn as Chief Medical Officer
November 14, 2023
 · 
3 min read
BioMidwest
Humanetics Corporation Receives Funding to Study New Drug for Idiopathic Pulmonary Fibrosis
October 24, 2023
 · 
3 min read
BioMidwest
Humanetics Corporation Publishes Positive Clinical Trial Results of BIO 300 in Patients with Non-Small Cell Lung Cancer
September 19, 2023
 · 
3 min read
BioMidwest
Humanetics Corporation Awarded Contract From Department of Defense to Develop First FDA Approved Drug to Prevent Radiation Injury
September 6, 2023
 · 
3 min read
Drug Development
ONL Therapeutics Completes Enrollment in Phase 2 Study of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
August 28, 2023
 · 
3 min read
Load More
JOBS